Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...

From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

Sanofi-backed Abcuro has secured $200 million in series C funds to power its anti-KLRG1 antibody through a phase 2/3 muscle ...

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

Headline annual inflation is seen rising 2.9% and core CPI is forecast to increase 3.1%. Investors should brace for... Week Ahead: CPI Report Threatens to Destabilize Rates By Michael Kramer - Feb ...

U.S. consumer prices rise by 3.0% in January, faster than anticipated By Investing.com - Feb 12, 2025 54 Investing.com - U.S. consumer prices rose by more than expected in January, pointing to ...

Molson Coors Beverage Co. Cl A-6.56% $11.13B Molson Coors Beverage Co. Cl B-1.02% $11.13B ...

After hours: February 11 at 4:08:14 PM EST ...

Non-Blocking Reactive Streams Foundation for the JVM both implementing a Reactive Extensions inspired API and efficient event streaming support. Since 3.3.x, this repository also contains ...

Financial objective: The Sub-fund aims to outperform (after deduction of costs) the MSCI ACWI Index, as stated in sterling, by at least 2% per annum over rolling five-year periods. Sustainability ...